These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1688305)

  • 1. Studies of specificity and inhibition of human cerebrospinal fluid dynorphin converting enzyme.
    Demuth HU; Nyberg F
    J Enzyme Inhib; 1991; 4(4):299-306. PubMed ID: 1688305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proteases with enkephalin-analogue inhibitors.
    Demuth HU; Silberring J; Nyberg F
    J Enzyme Inhib; 1991; 4(4):289-98. PubMed ID: 1669830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bovine spinal cord endoprotease with high specificity for dynorphin B.
    Silberring J; Nyberg F
    J Biol Chem; 1989 Jul; 264(19):11082-6. PubMed ID: 2567732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a secreted arginine-specific dibasic cleaving enzyme from EL-4 cells.
    Csuhai E; Safavi A; Hersh LB
    Biochemistry; 1995 Sep; 34(38):12411-9. PubMed ID: 7547986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acids.
    Nyberg F; Nordström K; Terenius L
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1069-74. PubMed ID: 2864927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of leumorphin (dynorphin B-29) to dynorphin B and dynorphin B-14 by thiol protease activity.
    Devi L; Goldstein A
    J Neurochem; 1986 Jul; 47(1):154-7. PubMed ID: 2872272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
    Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
    Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin converting enzyme with unusual specificity from rat brain.
    Devi L; Goldstein A
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1892-6. PubMed ID: 6143321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dynorphin converting enzymes from human spinal cord by N-peptidyl-O-acyl hydroxylamines.
    Silberring J; Demuth HU; Brostedt P; Nyberg F
    J Biochem; 1993 Nov; 114(5):648-51. PubMed ID: 8113215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid dynorphin-converting enzyme activity is increased by voluntary exercise in the spontaneously hypertensive rat.
    Persson S; Jónsdóttir I; Thorén P; Post C; Nyberg F; Hoffmann P
    Life Sci; 1993; 53(8):643-52. PubMed ID: 8350680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoforms of a dynorphin B converting enzyme isolated by column electrophoresis in agarose suspension.
    Silberring J; Nyberg F
    Biochem Int; 1991 Jan; 23(1):103-10. PubMed ID: 1677805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of N-peptidyl-O-acyl hydroxylamines on dynorphin-induced antinociception in the mouse capsaicin test.
    Tan-No K; Taira A; Nakagawasai O; Niijima F; Demuth HU; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2005 Dec; 39(6):569-73. PubMed ID: 16271759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain endo-oligopeptidase A, a putative enkephalin converting enzyme.
    Camargo AC; Oliveira EB; Toffoletto O; Metters KM; Rossier J
    J Neurochem; 1987 Apr; 48(4):1258-63. PubMed ID: 2880931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate modulation of dynorphin conversion in primary cultures of rat cerebral cortex.
    Vlaskovska M; Nylander I; Schramm M; Hahne S; Kasakov L; Silberring J; Terenius L
    Brain Res; 1997 Jun; 760(1-2):85-93. PubMed ID: 9237522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a dynorphin-processing endopeptidase.
    Berman YL; Juliano L; Devi LA
    J Biol Chem; 1995 Oct; 270(40):23845-50. PubMed ID: 7559562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of dynorphin-(1-13) and dynorphin-(1-17) by the neuroblastoma cell membrane. Evidence for the involvement of a cysteine protease.
    Satoh M; Yokosawa H; Ishii S
    Biochem Biophys Res Commun; 1986 Oct; 140(1):335-41. PubMed ID: 2877660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of the dynorphins to Leu-enkephalin in human spinal cord.
    Nyberg F; Silberring J
    Prog Clin Biol Res; 1990; 328():261-5. PubMed ID: 1968264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid activity of dynorphin-converting enzyme at term pregnancy.
    Lyrenäs S; Nyberg F; Lindberg B; Terenius L
    Obstet Gynecol; 1988 Jul; 72(1):54-8. PubMed ID: 2898124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test.
    Tan-No K; Taira A; Sakurada T; Inoue M; Sakurada S; Tadano T; Sato T; Sakurada C; Nylander I; Silberring J; Terenius L; Kisara K
    Eur J Pharmacol; 1996 Oct; 314(1-2):61-7. PubMed ID: 8957219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry.
    Bivehed E; Strömvall R; Bergquist J; Bakalkin G; Andersson M
    Peptides; 2017 Jan; 87():20-27. PubMed ID: 27840228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.